HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Wellness Industry Group News: GOED Details Selling On Amazon, Decade Of ‘One Voice’ For DSTA

Executive Summary

FDA’s Welch To Open AHPA’s Botanical Congress in May; CRN Adds WellComms To Event Schedule; GOED, ClearCut Webinar Details Selling Fatty Acids On Amazon; and DTSA Marks 10 Years Of ‘One Voice’.

You may also be interested in...



Amazon’s Dietary Supplement Quality Control Standards Well-Intended But Short-Sighted

Amazon’s quality control requirements for supplements shouldn’t rely on third-party certification for finished-product specifications but on FDA’s GMPs, says consultant Tara Couch. Attorneys Robert Durkin and Kevin Bell say companies are gaming the system by submitting fraudulent CoAs.

CBD Regulation Bill Filed In US House Again; VMS In Pre-Tax Savings Accounts In First Senate Vote

Hemp-Derived CBD bill either provides exact solution US needs for lawful use of cannabinoids as dietary ingredients or falls well short, depending on the trade group. Legislation to expand health savings accounts to include vitamin, mineral and supplement products reached Senate floor vote before failing.

Quick Listen: Scrip’s Five Must-Know Things

In this week's podcast episode of Five Must-Know Things, hear about issues surrounding the proposed IP waiver for coronavirus vaccines, a trial delay for Novavax’s COVID-19 vaccine, an ICER review of multiple myeloma drugs and Galapagos’ efforts to refocus its R&D pipeline.

Topics

UsernamePublicRestriction

Register

RS151264

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel